Initial treatment outcome and feasibility of low-dose cabazitaxel against docetaxel- and castration-resistant prostate cancer in a Japanese hospital

Introduction: Cabazitaxel (CBZ) is used worldwide for castration-resistant prostate cancer after docetaxel treatment. In July 2014 the drug was approved in Japan with the same induction dose used for Caucasian patients. In this study, we examined and compared the results of an initial low-dose CBZ t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Rural Med
Main Authors: Chaya, Ryosuke, Okamura, Takehiko, Yanase, Takahiro, Nagai, Takashi, Moritoki, Yoshinobu, Kobayashi, Daichi, Akita, Hidetoshi, Yasui, Takahiro
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Association of Rural Medicine 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983453/
https://ncbi.nlm.nih.gov/pubmed/32015778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2185/jrm.2019-004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados